Pharmaceutical - Asia-Pacific

Filter

Current filters:

Asia-Pacific

Popular Filters

176 to 200 of 749 results

Wockhardt hit hard by MHRA’s withdrawal of certificate

Wockhardt hit hard by MHRA’s withdrawal of certificate

15-10-2013

Indian drugmaker Wockhardt has had its Good Manufacturing Practice certificate revoked by the UK’s…

Asia-PacificPharmaceuticalProductionRegulationWockhardt

Ono sets up subsidiary in South Korea

14-10-2013

Japanese drugmaker Ono Pharmaceutical has decided to establish a new fully owned subsidiary in South…

Asia-PacificManagementMarkets & MarketingPharmaceutical

AstraZeneca to co-promote Janssen prostate cancer drug in Japan

AstraZeneca to co-promote Janssen prostate cancer drug in Japan

11-10-2013

Anglo-Swedish drug major AstraZeneca has entered into an agreement with US health care giant Johnson…

abirateroneAsia-PacificAstraZenecaJanssenJohnson & JohnsonLicensingMarkets & MarketingOncologyPharmaceuticalZytiga

Lilly acquires rights to Hutchison MediPharma cancer drug candidate

Lilly acquires rights to Hutchison MediPharma cancer drug candidate

09-10-2013

Hutchison MediPharma, an R&D company majority owned by China’s Chi-Med, has entered into a licensing,…

Asia-PacificEli LillyfruquintinibHutchison MediPharmaLicensingOncologyPharmaceutical

“Don’t import NZ medicines system,” warns Medicines Australia

09-10-2013

Speaking at a Medicines New Zealand conference in Auckland today (October 9), pharma trade group Medicines…

Asia-PacificFinancialHealthcarePharmaceutical

EU and Japan improve information-sharing using EudraGMDP database

EU and Japan improve information-sharing using EudraGMDP database

08-10-2013

Information will be shared between Japan and the European Union about good practice compliance relating…

Asia-PacificEuropePharmaceuticalRegulation

Medicines Australia questions spending on medicines

08-10-2013

Australians are seeing their access to new medicines on the Pharmaceutical Benefits Scheme delayed while…

Asia-PacificFinancialHealthcarePharmaceuticalPolitics

Asia-Pacific solid tumors market to reach $2.3 billion by 2019

08-10-2013

The Asia-Pacific solid tumors treatment markets - bladder, ovarian, pancreatic and prostate cancers -…

Asia-PacificMarkets & MarketingOncologyPharmaceuticalPricing

Japanese lawmakers are stepping in to Diovan investigation

07-10-2013

Members of Japan’s Diet (Congressmen) have formed a bipartisan study group to examine Swiss drug major…

Asia-PacificCardio-vascularDiovanNovartisPharmaceuticalPoliticsRegulationResearch

Debiopharm collaborates with A*STAR’s ETC on oncology targets

07-10-2013

Swiss independent drug developer Debiopharm has signed an exclusive research collaboration with the Singapore-based…

A*STARAsia-PacificDebiopharmOncologyPharmaceuticalResearch

PeptiDream and Ipsen expand their peptide drug collaboration to treat endocrinologic disease

07-10-2013

PeptiDream and Ipsen have expanded the scope of their April 2013 research collaboration and license option…

Asia-PacificGastro-intestinalsIpsenLicensingPeptiDreamPharmaceutical

Takeda partners with newly-formed Tri-1 TDI

Takeda partners with newly-formed Tri-1 TDI

07-10-2013

The USA’s Memorial Sloan-Kettering Cancer Center, The Rockefeller University and Weill Cornell Medical…

Asia-PacificFinancialNorth AmericaPharmaceuticalResearchTakeda Pharmaceuticals

Hutchison China MediTech well placed to tap opportunities in China, say analysts

07-10-2013

Favorable demand trends, coupled with the supportive environment for clinical research, mean the prospects…

Asia-PacificFinancialHutchison MediPharmaHutchison MediTechPharmaceuticalResearch

Indian pharmaceutical market to reach $56 billion by 2020, says GlobalData

03-10-2013

Driven by the country’s growing economy and population income, the Indian pharmaceutical market will…

Asia-PacificMarkets & MarketingPatentsPharmaceuticalRegulation

Japan’s drug pricing authority hears opinions from pharma industry

Japan’s drug pricing authority hears opinions from pharma industry

30-09-2013

Japan’s Central Social Insurance Medical Council held a meeting last week of its Drug Pricing Subcommittee…

Asia-PacificPharmaceuticalPoliticsPricing

Astellas’ antifungal study reports positive results

30-09-2013

Astellas Pharma has announced positive topline data from the Phase III invasive aspergillosis study (SECURE)…

Asia-PacificAstellas PharmaBasilea PharmaceuticaDermatologicalsisavuconazolePharmaceuticalResearch

Nippon Shinyaku and Pfizer conclude exclusive sales promotion on Tramal

30-09-2013

Nippon Shinyaku and Pfizer have concluded an exclusive sales promotion consignment contract in Japan…

Asia-PacificLicensingMarkets & MarketingNeurologicalNippon ShinyakuPfizerPharmaceuticalTramadol Hydrochloride

Novartis under investigation for manipulating data in Japanese clinical trials

Novartis under investigation for manipulating data in Japanese clinical trials

27-09-2013

Swiss drug major Novartis has said it regrets the inconvenience caused by its investigator-initiated…

Asia-PacificCardio-vascularLegalNovartisPharmaceuticalRegulationvalsartan

Singapore to launch collaborative program into skin research

27-09-2013

Singapore is committing close to S$100 million ($79.6 million) to skin research, announced the Skin Research…

Asia-PacificDermatologicalsPharmaceuticalResearch

CSL Behring’s Hizentra approved in Japan for PID and SID

CSL Behring’s Hizentra approved in Japan for PID and SID

27-09-2013

The Japanese Ministry of Health, Labor and Welfare has approved Hizentra for the treatment of primary…

Asia-PacificCSL BehringHizentraImmunologicalsPharmaceuticalRare diseasesRegulation

Phebra gains right to market Syntometrine in Australia

Phebra gains right to market Syntometrine in Australia

27-09-2013

Phebra has signed an exclusive commercial agreement with UK-based pharmaceutical firm Alliance Pharma…

Alliance PharmaAsia-PacificLicensingPharmaceuticalSyntometrineWomen's Health

Japan's MHLW responded to requests for deregulation

Japan's MHLW responded to requests for deregulation

23-09-2013

The Japanese Ministry of Health, Labor and Welfare (MHLW) has pledged to study a scheme that would allow…

Asia-PacificHealthcarePharmaceutical

CHMP positive decision for Kadcyla, and approval in Japan

20-09-2013

The cancer drug Kadcyla (trastuzumab emtansine) has today received a positive opinion from the European…

Asia-PacificEuropeImmunoGenKadcylaOncologyPharmaceuticalRegulationRoche

176 to 200 of 749 results

Back to top